✦ LIBER ✦

Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis

✍ Scribed by Yoshiko Nomura; Masaya Segawa

Book ID: 114249098
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 572 KB
Volume: 25
Category: Article
ISSN: 0387-7604
DOI: 10.1016/s0387-7604(03)90007-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuropsychiatric disorders of childhood:

Neuropsychiatric disorders of childhood: Tourette's syndrome as a model

✍ DJ Cohen; JF Leckman; D. Pauls 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

Dopamine dysregulation syndrome: implica

Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

✍ M. Berk; S. Dodd; M. Kauer-Sant’Anna; G. S. Malhi; M. Bourin; F. Kapczinski; T. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

The use of botulinum toxin type A (BoNT/

The use of botulinum toxin type A (BoNT/A) as an adjunctive treatment modality for phonic tics on a series of 30 patients affected with tourette's syndrome (TS)

✍ Porta Mauro; M. Sassi; D. Servello 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 37 KB

A multicenter randomized placebo-control

A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome

✍ Roger Kurlan; Giovanna Crespi; Barbara Coffey; Kirsten Mueller-Vahl; Stephen Kov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

Background: Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome. Methods: There was a multicenter randomized, placebo-controlled, double-blind clinical trial of pramipexole given for 6 weeks in 63 children and adolescents with Touret